Cell cycle regulation of menin expression

Cancer Research

Volumn 59, Issue 20, 1999, Pages 5097-5101

  Kaji, Hiroshi ^a   Canaff, Lucie ^a   Goltzman, David ^a   Hendy, Geoffrey N ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MENIN PROTEIN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM;

AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE; CELL LINE; CELL NUCLEUS; COS CELLS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PITUITARY GLAND; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-JUN; RATS;

EID: 0032748585     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Metz, D. C., Jensen, R. T., Bale, A. E., Skarulis, M. C., Eastman, R. C., Nieman, L., Norton, J. A., Friedman, E., Larsson, C., Amorosi, A., Brandi, M-L., and Marx, S. J. Multiple endocrine neoplasia type 1. Clinical features and management. In: J. P. Bilezikian, M. A. Levine, and R. Marcus (eds.), The Parathyroids Basic and Clinical Concepts, pp. 591-646. New York: Raven Press, 1994.
2. Thakker, R. V. Multiple endocrine neoplasia type 1. In: L. DeGroot, G. M. Besser, H. G. Burger, J. L. Jameson, D. L. Loriaux, J. C. Marshall, W. D. Odel, J. T. Potts, Jr., and A. H. Rubenstein (eds.), Endocrinology, pp. 2815-2831. Philadelphia: W. B. Saunders, 1995.
3. Larsson, C., Skogseid, B., Oberg, K., Nakamura, Y., and Nordenskjold, M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature (Lond.), 332: 85-87, 1988.
4. Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S. E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., Crabtree, J. S., Wang, Y., Roe, B. A., Weisemann, J., Boguski, M. S., Agarwal, S. K., Kester, M. B., Kim, Y. S., Heppner, C., Dong, Q., Spiegel, A. M., Burns, A. L., and Marx, S. J. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (Washington DC), 276: 404-407, 1997.
5. The European Consortium on MEN1. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Hum. Mol. Genet., 6: 1177-1183, 1997.
6. Thakker, R. V. Editorial: multiple endocrine neoplasia-syndromes of the twentieth century. J. Clin. Endocrinol. Metab., 83: 2617-2620, 1998.
7. Marx, S. J., Agarwal, S. K., Kester, M. B., Heppner, C. A., Kim, Y. S., Skarulis, M. C., James, L. A., Goldsmith, P. K., Saggar, S. K., Parks, S. Y., Spiegel, A. M., Burns, A. L., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., Emmert-Buck, M. R., Guru, S. C., Manickam, P., Crabtree, J., Erdos, M. R., Collins, F. S., and Chandrasekharappa, S. C. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent Prog. Horm. Res., 54: 397-439, 1999.
8. Guru, S. C., Goldsmith, P. K., Burns, A. L., Marx, S. J., Spiegel, A. M., Collins, F. S., and Chandrasekharappa, S. C. Menin, the product of the MEN1 gene, is a nuclear protein. Proc. Natl. Acad. Sci. USA, 95: 1630-1634, 1998.
9. Agarwal, S. K., Guru, S. C., Heppner, C., Erdos, M. R., Collins, R. M., Park, S. Y., Saggar, S., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., Marx, S. J., and Bums, A. L. Menin interacts with the API transcription factor JunD and represses JunD-activated transcription. Cell, 96: 143-152, 1999.
10. Bertwistle, D., Swift, S., Marston, N. J., Jackson, L. E., Crossland, S., Crompton, M. R., Marshall, C. J., and Ashworth, A. Nuclear location and cell cycle regulation of the BRCA2 protein. Cancer Res., 57: 5485-5488, 1997.
11. Gudas, J. M., Li, T., Nguyen, H., Jensen, D., Rauscher, F. J., and Cowan, K. H. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ., 7: 717-723, 1996.
12. Abrams, H. D., Rohrschneider, L. R., and Eisenman, R. N. Nuclear location of the putative transforming protein of avian myelocylomatosis virus. Cell, 29: 427-439, 1982.
13. Vindelov, L. L. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and staining of nuclei. Virchows Archiv. B Cell Pathol., 24: 227-242, 1977.
14. Ye, Y., Vasavada, S., Kuzmin, I., Stackhouse, T., Zbar, B., and Williams, B. R. G. Subcellular localization of the Von Hippel-Lindau disease gene product is cell cycle-dependent. Int. J. Cancer. 78: 62-69, 1998.
15. Lam, M. H. C., Olsen, S. L., Rankin, W. A., Ho. P. W. M., Martin, T. J., Gillespie, M. T., and Moseley, J. M. PTHrP and cell division: expression and localization of PTHrP in a keratinocyte cell line (HaCaT) during the cell cycle. J. Cell. Physiol., 173: 433-446, 1997.
16. Vaughn, J. P., Davis, P. L., Jarboe, M. D., Huper, G., Evans, A. C., Wiseman, R. W., Berchuck, A., Iglehart, J. D., Futreal, P. A., and Marks, J. R. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ., 7: 711-715, 1996.
17. Li, Y., Jenkins, C. W., Nichols, M. A., and Xiong, Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene, 9: 2261-2268, 1994.
18. 1 cyclin-cdk protein kinase activity, is related to p21. Cell, 78: 67-74, 1994.
19. Reich, N. C., and Levine, A. J. Growth regulation of a cellular tumor antigen p53, in nontransformed cells. Nature (Lond.), 308: 199-201, 1984.
20. Lee, S., Chen, D. Y. T., Humphrey, J. S., Gnarra, J. R., Linehan, M., and Klausner, R. D. Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc. Natl. Acad. Sci. USA, 93: 1770-1775, 1996.
21. Huang, S. C., Zhuang, Z., Weil, R. J., Pack, S., Wang, C., Krutzsch, H. C., Pham, T. A., and Lubensky, I. A. Nuclear/cytoplasmic localization of the multiple endocrine neoplasia type 1 gene product, menin. Lab. Investig., 79: 301-310, 1999.
22. Wang, H., Xie, Z., and Scott, R. E. Differentiation modulates the balance of positive and negative Jun/AP-1 DNA binding activities to regulate cellular proliferative potential: different effects in nontransformed and transformed cells. J. Cell Biol., 135: 1151-1162, 1996.
23. Castellazzi, M., Spyrou, G., La Vista, N., Dangy, J. P., Piu, F., Yaniv, M., and Brun, G. Overexpression of c-jun, junB, or junD affects cell growth differently. Proc. Natl. Acad. Sci. USA, 88: 8890-8894, 1991.
24. Hirai, S., Ryseck, R. P., Mechta, F., Bravo, R., and Yaniv, M. Characterization of junD: a new member of the jun proto-oncogene family. EMBO J., 8: 1433-1439, 1989.
25. Pfarr, C. M., Mechta, F., Spyrou, G., Lallemand, D., Carillo, S., and Yaniv, M. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell, 76: 747-760, 1994.
26. Lallemand, D., Spyrou, G., Yaniv, M., and Pfarr, C. M. Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts. Oncogene, 14: 819-830, 1997.
27. McCabe, L. R., Banerjee, C., Kundu, R., Harrison, R. J., Dobner, P. R., Stein, J. L., Lian, J. B., and Stein, G. S. Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and JunD during differentiation. Endocrinology, 137: 4398-4408, 1996.